Publications in SCI(E) Journals (First author or co-first author)
1. Hanbyoul Cho, Soon Won Hong, Youn Jin Oh, Min A Kim, Eun Suk Kang, Jong Min Lee, Sang Wun Kim, Sung Hoon Kim, Jae Hoon Kim, Young Tae Kim, Kook Lee. Clinical significance of osteopontin expression in cervical cancer. J Cancer Res Clin Oncol. 2008 Aug;134(8):909-17.
2. Hanbyoul Cho, Eun Suk Kang, Soon Won Hong, Youn Jin Oh, Sun Mi Choi, Sang Wun Kim, Sung Hoon Kim, Young Tae Kim, Kyoung Sun Lee, Yang Kyu Choi, Jae-Hoon Kim. Genomic and proteomic characterization of YDOV-157, a newly established human epithelial ovarian cancer cell line. Mol Cell Biochem. 2008 Dec;319(1-2):189-201.
3. Hanbyoul Cho, Hye Won Hur, Sang Wun Kim, Sung Hoon Kim, Jae Hoon Kim, Young Tae Kim, Kook Lee. Pre-treatment neutrophil to lymphocyte ratio is elevated in epithelial ovarian cancer and predicts survival after treatment. Cancer Immunol Immunother. 2009 Jan;58(1):15-23.
4. Hanbyoul Cho, Eun Suk Kang, Young Tae Kim, Jae-Hoon Kim. Diagnostic and prognostic impact of osteopontin expression in endometrial cancer. Cancer Invest. 2009 Mar;27(3):313-23.
5. Hanbyoul Cho, Jae-Hoon Kim. Lipocalin2 Expressions Correlate Significantly with Tumor Differentiation in Epithelial Ovarian Cancer. J Histochem Cytochem. 2009 May;57(5):513-21.
6. Hanbyoul Cho, Jae-Hoon Kim. Multiplication of neutrophil and monocyte counts (MNM) as an easily obtainable tumor marker for cervical neoplasia. Biomarkers 2009 May;14(3):161-70.
7. Hanbyoul Cho, Beom Jin Lim, Eun Suk Kang, Joong Sub Choi, Jae-Hoon Kim. Molecular Characterization of a New Ovarian Cancer Cell Line, YDOV-151, Established from Mucinous Cystadenocarcinoma. Tohoku J Exp Med. 2009 June;218(2):129-39.
8. Hanbyoul Cho, Mi Kyung Kim, Jae Kwan Lee, Sung Kyong Son, Kwang-Beom Lee, Jong-Min Lee, Jung Pil Lee, Soo Young Hur, Jae-Hoon Kim. Relationship of serum antioxidant micronutrients and sociodemographic factors to cervical neoplasia: A case-control study. Clin Chem Lab Med. 2009 July;47(8):1005-12.
9. Hanbyoul Cho, Jae-Hoon Kim. Treatment of the patients with abnormal cervical cytology: A “see-and-treat” versus three-step strategy. J Gynecol Oncol. 2009 Sep;20(3):164-168. [SCIE]
10. Hanbyoul Cho, Young Tae Kim, Jae-Hoon Kim. Accuracy of preoperative tests in clinical stage I endometrioid endometrial cancer. Acta Obstet Gynecol Scand. 2010 Feb;89(2):175-81.
11. Kyung Hee Noh, Bo Wook Kim, Kwon-Ho Song, Hanbyoul Cho, Young-Ho Lee, Jin Hee Kim, Joon-Yong Chung, Jae-Hoon Kim, Stephen M. Hewitt, Seung-Yong Seong, Chih-Ping Mao, T-C Wu, and Tae Woo Kim. Nanog signaling in cancer promotes stem-like phenotype and immune evasion. J Clin Invest. 2012 Nov 1;122(11):4077-93. [Co-first Author]
12. Hanbyoul Cho, Jane Seon-Young Kim, Hyunsoo Chung, Candice Perry, Heejeong Lee, Jae-Hoon Kim. Loss of ARID1A/BAF250a expression is linked to tumor progression and adverse prognosis in cervical cancer. Hum Pathol. 2013 Jul;44(7):1365-74.
13. Bo Wook Kim, Hanbyoul Cho, Joon-Yong Chung, Catherine Conway, Kris Ylaya, Jae-Hoon Kim, Stephen M. Hewitt. Prognostic assessment of hypoxia and metabolic markers in cervical cancer using automated digital image analysis of immunohistochemistry. J Transl Med. 2013 Aug 8;11:185. [Co-first Author]
14. Hyunsoo Chung, Hanbyoul Cho, Candice Perry, Jaekyung Song, Kris Ylaya, Heejeong Lee, Jae-Hoon Kim. Downregulation of ERp57 expression is associated with poor prognosis in early-stage cervical cancer. Biomarkers. 2013 Nov;18(7):573-9. [Co-first Author]
15. Hanbyoul Cho, You Sun Lee, Julie Kim, Joon-Yong Chung, Jae-Hoon Kim. Overexpression of glucose transporter-1 (GLUT-1) predicts poor prognosis in epithelial ovarian cancer. Cancer Invest. 2013 Nov;31(9):607-15.
16. Hanbyoul Cho, Sunghoon Kim, Ha-Yeon Shin, Eun Joo Chung, Haruhisa Kitano, Jae Hyon Park, Lucienne Park, Joon-Yong Chung, Stephen M. Hewitt, Jae-Hoon Kim. Expression of stress-induced phosphoprotein1 (STIP1) is associated with tumor progression and poor prognosis in epithelial ovarian cancer. Genes Chromosomes Cancer. 2014 Apr;53(4):277-88.
17. Hanbyoul Cho, Kyung Hee Noh, Joon-Yong Chung, Mikiko Takikita, Eun Joo Chung, Bo Wook Kim, Stephen M. Hewitt, Tae Woo Kim, Jae-Hoon Kim. Synaptonemal complex protein 3 is a prognostic marker in cervical cancer. PLoS One. 2014 Jun 6;9(6):e98712.
18. Hanbyoul Cho, Ha-Yeon Shin, Sunghoon Kim, Jane Seon-Young Kim, Joon-Yong Chung, Eun Joo Chung, Kyung-Hee Chun, Stephen M. Hewitt, Jae-Hoon Kim. The role of S100A14 in epithelial ovarian tumors. Oncotarget. 2014 Jun 15;5(11):3482-96.
19. Hanbyoul Cho, Byung-Ho Nam, Seok Mo Kim, Chi-Heum Cho, Byoung Gie Kim, Hee-Sug Ryu, Soon Beom Kang, Jae-Hoon Kim. A Phase 2 Trial of Radiation Therapy With Concurrent Paclitaxel Chemotherapy After Surgery in Patients With High-Risk Endometrial Cancer: A Korean Gynecologic Oncologic Group Study. Int J Radiat Oncol Biol Phys. 2014 Jul 8. pii: S0360-3016(14)00624-5. doi: 10.1016/j.ijrobp.2014.05.024. [Epub ahead of print]
Publications in SCI(E) Journals (Co-author)
1. SiHyun Cho, Hanbyoul Cho, Anna Nam, Hye Yeon Kim, Young Sik Choi, Ki Hyun Park, Dong Je Cho, Byung Seok Lee. Neutrophil-lymphocyte ratio as an adjunct to CA-125 for the diagnosis of endometriosis. Fertil Steril. 2008 Dec;90(6):2073-79.
2. Sunghoon Kim, Hanbyoul Cho, Eun Ji Nam, Sang Wun Kim, Young Tae Kim, Yong Won Park, Bo Wook Kim, Jae-Hoon Kim. Autoantibodies against stress-induced phosphoprotein-1 as a novel biomarker candidate for ovarian cancer. Genes Chromosomes Cancer. 2010 Jul;49(7):585-95.
3. Doobyung Chay, Hanbyoul Cho, Beom Jin Lim, Eun Suk Kang, Yoon Jin Oh, Sun Mi Choi, Bo Wook Kim, Young Tae Kim, Jae-Hoon Kim. ER-60 (PDIA3) is highly expressed in a newly established serous ovarian cancer cell line, YDOV-139. Int J Oncol. 2010 Aug;37(2):399-412.
4. Mikiko Takikita, Ran Xie, Joon-Yong Chung, Hanbyoul Cho, Kris Ylaya, Seung-Mo Hong, Christopher A Moskaluk, Stephen M Hewitt. Membranous expression of Her3 is associated with a decreased survival in head and neck squamous cell carcinoma. J Transl Med. 2011 Jul 29;9:126.
5. Bo Wook Kim, Hanbyoul Cho, Hyunki Kim, Eun Ji Nam, Sang Wun Kim, Sunghoon Kim, Young Tae Kim, Jae-Hoon Kim. Human chorionic gonadotrophin regression rate as a predictive factor of postmolar gestational trophoblastic neoplasm in high-risk hydatidiform mole: a case-control study. Eur J Obstet Gynecol Reprod Biol. 2012 Jan;160(1):100-5.
6. Bo Wook Kim, Young Eun Jeon, Hanbyoul Cho, Eun Ji Nam, Sang Wun Kim, Sunghoon Kim, Young Tae Kim, Jae-Hoon Kim. Pre-treatment diagnosis of endometrial cancer through a combination of CA125 and multiplication of neutrophil and monocyte. J Obstet Gynaecol Res. 2012 Jan;38(1):48-56.
7. Doo Byung Chay, Hanbyoul Cho, Bo Wook Kim, Eun Suk Kang, Eunseop Song, Jae-Hoon Kim. Clinical significance of serum anti-human papillomavirus 16 and 18 antibodies in cervical neoplasia. Obstet Gynecol. 2013 Feb;121(2 Pt 1):321-9.
8. Joon-Yong Chung, Haruhisa Kitano, Mikiko Takikita, Hanbyoul Cho, Kyung Hee Noh, Tae Woo Kim, Kris Ylaya, Jun Hanaoka, Junya Fukuoka, Stephen M. Hewitt. Synaptonemal complex protein 3 as a novel prognostic marker in early stage non-small cell lung cancer. Hum Pathol. 2013 Apr;44(4):472-9.
로봇을 이용한 자궁근종절제술의 유용성: 복강경 그리고 개복수술과 비교
대한산부인과학회지 54/12 :784-793,2011
Human chorionic gonadotrophin regression rate as a predictive factor of postmolar gestational trophoblastic neoplasm in high-risk hydatidiform mole: A case-control study
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY 160/1 :100-105,2012
Pre-treatment diagnosis of endometrial cancer through a combination of CA125 and multiplication of neutrophil and monocyte
JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH 38/1 :48-56,2012
Nanog signaling in cancer promotes stem-like phenotype and immune evasion
JOURNAL OF CLINICAL INVESTIGATION 122/11 :4077-4093,2012
Clinical significance of serum anti-human papillomavirus 16 and 18 antibodies in cervical neoplasia
OBSTETRICS AND GYNECOLOGY 121/2 :321-329,2013
The ON-Q pain management system in elective gynecology oncologic surgery: Management of postoperative surgical site pain compared to intravenous patient-controlled analgesia
Obstetrics & Gynecology Science 56/02 :93-101,2013
Loss of ARID1A/BAF250a expression is linked to tumor progression and adverse prognosis in cervical cancer.
HUMAN PATHOLOGY 44/7 :1365-1374,2013
Prognostic assessment of hypoxia and metabolic markers in cervical cancer using automated digital image analysis of immunohistochemistry.
JOURNAL OF TRANSLATIONAL MEDICINE 11/185 :1-11,2013
Overexpression of Glucose Transporter-1 (GLUT-1) Predicts Poor Prognosis in Epithelial Ovarian Cancer.
CANCER INVESTIGATION 31/9 :607-615,2013
Downregulation of ERp57 expression is associated with poor prognosis in early-stage cervical cancer
BIOMARKERS 18/7 :573-579,2013
Synaptonemal complex protein 3 as a novel prognostic marker in early stage non-small cell lung cancer
HUMAN PATHOLOGY 44/4 :472-479,2013
Expression of Stress-Induced Phosphoprotein1 (STIP1) is Associated with Tumor Progression and Poor Prognosis in Epithelial Ovarian Cancer
GENES CHROMOSOMES & CANCER 53/4 :277-288,2014
Synaptonemal Complex Protein 3 Is a Prognostic Marker in Cervical Cancer
PLOS ONE 9/6 :e98712-,2014
The role of S100A14 in epithelial ovarian tumors
ONCOTARGET 5/ :3482-3496,2014
Apoptosis inhibitor-5 overexpression is associated with tumor progression and poor prognosis in patients with cervical cancer
BMC CANCER 14/545 :1-2,2014
A Phase 2 Trial of Radiation Therapy With Concurrent Paclitaxel Chemotherapy After Surgery in Patients With High-Risk Endometrial Cancer: A Korean Gynecologic Oncologic Group Study
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS 90/1 :140-146,2014
MICA/B and ULBP1 NKG2D ligands are independent predictors of good prognosis in cervical cancer.
BMC CANCER 14/957 :1-11,2014
ATP-Based Chemotherapy Response Assay in Primary or Recurrent Ovarian and Peritoneal Cancer
YONSEI MEDICAL JOURNAL 55/6 :1664-1671,2014
PI3K/AKT activation induces PTEN ubiquitination and destabilization accelerating tumourigenesis.
NATURE COMMUNICATIONS 6/7769 :1-14,2015
Prognostic Significance of AMP-Dependent Kinase Alpha Expression in Cervical Cancer
PATHOBIOLOGY 82/5 :203-211,2015
Assessment of a panel of tumor markers for the differential diagnosis of benign and malignant effusions by well-based reverse phase protein array
DIAGNOSTIC PATHOLOGY 10/53 :1-10,2015
Prognostic role and implications of mutation status of tumor suppressor gene ARID1A in cancer: a systematic review and meta-analysis.
ONCOTARGET 6/36 :39088-39097,2015
Clinical significance of OCT4 and SOX2 protein expression in cervical cancer
BMC CANCER 15/ :1,015-1,022,2015
Makorin Ring Finger Protein 1 as Adjunctive Marker in Liquid-based Cervical Cytology
MEDICINE 95/3 :2,425-2,430,2016
Clinical Significance of CA125 Level after the First Cycle of Chemotherapy on Survival of Patients with Advanced Ovarian Cancer
YONSEI MEDICAL JOURNAL 57/3 :580-587,2016
The paraffin-embedded RNA metric (PERM) for RNA isolated from formalin-fixed, paraffin-embedded tissue
BIOTECHNIQUES 60/5 :239-244,2016
Accumulation of cytoplasmic Cdk1 is associated with cancer growth and survival rate in epithelial ovarian cancer
ONCOTARGET 7/31 :49,481-49,497,2016
A melanin-bleaching methodology for molecular and histopathological analysis of formalin-fixed paraffin-embedded tissue.
LABORATORY INVESTIGATION 96/10 :1,116-1,127,2016
Over-expression of BMI1 is associated with favorable prognosis in cervical cancer
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY 9/2 :1,849-1,857,2016
Practice guidelines for management of uterine corpus cancer in Korea: a Korean Society of Gynecologic Oncology Consensus Statement
JOURNAL OF GYNECOLOGIC ONCOLOGY 28/1 :12-33,2017
REP1 inhibits FOXO3-mediated apoptosis to promote cancer cell survival
CELL DEATH & DISEASE 8/1 :e2536-,2017
Bcl-2-like Protein 11 (BIM) Expression Is Associated with Favorable Prognosis for Patients with Cervical Cancer
ANTICANCER RESEARCH 37/9 :4,873-4,879,2017
HDAC1 Upregulation by NANOG Promotes Multidrug Resistance and a Stem-like Phenotype in Immune Edited Tumor Cells.
CANCER RESEARCH 77/18 :5,039-5,053,2017
API5 induces cisplatin resistance through FGFR signaling in human cancer cells
EXPERIMENTAL AND MOLECULAR MEDICINE 49/9 :e374-1-e374-10,2017
Prognostic implication of programmed cell death 1 protein and its ligand expressions in endometrial cancer.
GYNECOLOGIC ONCOLOGY 149/2 :381-387,2018
Targeting Cyclin D-CDK4/6 Sensitizes Immune-Refractory Cancer by Blocking the SCP3-NANOG Axis
CANCER RESEARCH 78/10 :2,638-2,653,2018
Oncogene-induced senescence mediated by c-Myc requires USP10 dependent deubiquitination and stabilization of p14ARF
CELL DEATH AND DIFFERENTIATION 25/6 :1050-1062,2018
Comparison of Clinical Features and Outcomes in Epithelial Ovarian Cancer according to Tumorigenicity in Patient-Derived Xenograft Models.
CANCER RESEARCH AND TREATMENT 50/3 :956-963,2018
DNA mismatch repair protein immunohistochemistry and MLH1 promotor methylation testing for practical molecular classification and the prediction of prognosis in endometrial cancer
Cancers 10/9 :279-293,2018
Histomorphological and Molecular Assessments of the Fixation Times Comparing Formalin and Ethanol-Based Fixatives
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY 66/2 :121-135,2018
Mitochondrial reprogramming via ATP5H loss promotes multimodal cancer therapy resistance
JOURNAL OF CLINICAL INVESTIGATION 128/9 :4,098-4,114,2018
Establishment of five immortalized human ovarian surface epithelial cell lines via SV40 T antigen or HPV E6/E7 expression
PLOS ONE 13/10 :e0205297-e0205312,2018
Preoperative serum levels of cancer antigen 125 and carcinoembryonic antigen ratio can improve differentiation between mucinous ovarian carcinoma and other epithelial ovarian carcinomas
Obstetrics & Gynecology Science 61/3 :344-351,2018
Combined treatment with modulated electro-hyperthermia and an autophagy inhibitor effectively inhibit ovarian and cervical cancer growth
INTERNATIONAL JOURNAL OF HYPERTHERMIA 36/1 :9-20,2019
ALDH1A2 Is a Candidate Tumor Suppressor Gene in Ovarian Cancer
Cancers 11/10 :E1553-,2019
Forkhead box protein O1 (FOXO1) and paired box gene 3 (PAX3) overexpression is associated with poor prognosis in patients with cervical cancer
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY 24/11 :1,429-1,439,2019
Loss of Both USP10 and p14ARF Protein Expression Is an Independent Prognostic Biomarker for Poor Prognosis in Patients With Epithelial Ovarian Cancer
CANCER GENOMICS & PROTEOMICS 16/6 :553-562,2019